Navigation Links
$16 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative-Effectiveness Research In Cancer
Date:10/5/2009

cancer research is done in patients in the early stages of their disease, so we know relatively little about patterns of treatment among patients whose cancer has recurred or progressed," said Paul Fishman, Ph.D., an associate investigator at Group Health and co-investigator on the project. "This study will provide evidence needed to support better care for more patients. Our research will be based on a wide range of patients who receive care in the full range of clinical settings where Americans receive their cancer care."

These GO grants represent just a fraction of federal stimulus funding for biomedical research awarded to these Seattle institutions. In total, as of Oct. 1, the UW schools of Medicine, Public Health and Pharmacy had received $79.6 million for 186 projects, the Hutchinson Center had received nearly $40.4 million for 60 projects, and Group Health had received more than $17 million for 15 projects.

About Fred Hutchinson Cancer Research Center -- At Fred Hutchinson Cancer Research Center, interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Center researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit www.fhcrc.org.

About the University of Washington School of Public Health -- The UW School of Public Health is one of 40 accredited schools of public health in the nation and the only one in the Northwest. The mission of the school is to promote better health, prevent illness and injury, and ensure more efficient and cost-effective health care services through education, research and service. The combination of discipline-oriented academic programs in the school's five departments and strong interdisciplinary research provides a setting for
'/>"/>

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Federal Stimulus Funding Channels More Than $40 Million to Fred Hutchinson Cancer Research Center
2. Global Death Toll: One Million Premature Babies Every Year
3. Global death toll: 1 million premature babies every year
4. 1 Million Preemie Babies Die Each Year: Report
5. USC neuroscientists awarded $9 million to map gene expression during human brain development
6. Einstein receives $2.1 million federal grant to support Hispanic Center of Excellence
7. American Veterinary Medical Foundation and Pfizer Animal Health Team Up to Award Up to $2 Million in Scholarships to Veterinary Students Through 2012
8. Hospital Group Receives $1 Million Grant to Help Patients Access Health Insurance
9. Half-million low-income elderly affected by sweeping cuts to state safety net
10. Construction Begins on $50 Million Campus for Autism and Developmental Disability Life Quality
11. Consumer Group Continues Million Dollar Campaign Responding to NYC Health Officials Hyperbolic PSA Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... a new study done from the heights of Mount ... increases if you ascend to great heights. They ... high blood pressure was ineffective once climbers reached above ... 27 in the European Heart Journal , could ... level who have sleep apnea, in which a blocked ...
(Date:8/27/2014)... 2014 BESLER Consulting , a ... for hospitals, is pleased to announce that it has ... America’s Fastest-Growing Companies. The list represents the most comprehensive ... entrepreneurs. , "It's been an exciting year for ... in this year's Inc. 5000 list,” said Jonathan Besler, ...
(Date:8/27/2014)... The American Brain Tumor Association ... Basic Research Fellowships and 2014-2015 Discovery Grant Awards. Through ... seeding the field with talented, bright young investigators who ... causes, effects, diagnosis and treatment of brain tumors. This ... on the potential to advance the understanding and treatment ...
(Date:8/27/2014)... drug designed to help regulate the blood,s iron supply shows ... according to results from the first human study ... , the Journal of the American Society of ... red blood cells are in short supply or do not ... not get enough oxygen, since there are fewer red blood ...
(Date:8/27/2014)... A new analysis of clinical trial participation in the ... has found participants are not representative of the larger ... College Hospital cardiologist Dr. Jay Udell. The study authors ... to the wider population, and suggest the use of ... trial participation. , "We know that clinical trials can ...
Breaking Medicine News(10 mins):Health News:Everest Study Finds High Altitude Affects Blood Pressure 2Health News:BESLER Consulting Among America’s Fastest Growing Private Companies 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Drug represents first potential treatment for common anemia 2Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2
... a combination of treatments tailor-made to their specific needs to ... immune response to cancer vaccines, because like the rest of ... efficient as we get older. Dr. Joseph Lustgarten, from the ... effects of aging on the immune system and strategies used ...
... are justified, say hearing loss experts who urge prevention , ... typically long -- and get longer when their children become ... about hearing loss. , Parents, in fact, worry more about ... health-related issues, including ear infections, sleep problems and asthma, according ...
... Greater Surface Disinfection to Combat Bad Hygiene , ARLINGTON, Va., ... standing in the lunch line? Or sneeze loudly into the ... (96 percent) have seen you do things like this -- and ... , Even with heightened concerns during this year,s flu season, ...
... , ... on the forefront of adopting social media outlets for physician recruitment , ... Alpharetta, GA (Vocus) October 8, 2009 -- "Jackson ... aspects of physician recruitment and other company functions," says company president, Sandra Garrett., , , ...
... ... malignancy after using a new treatment offered by NeoPlas Innovation. , ... Nashville, Tenn. (PRWEB) October 7, 2009 -- A patient ... after using a new treatment offered by NeoPlas Innovation . All evidence of disease ...
... Bipartisan Policy Center,s Health Care Report Urge Joint Leadership on ... is a statement released by Bipartisan Policy Center Founders and ... Bob Dole: , "After 14 months of work, on June ... It was the culmination of months of work as advisors ...
Cached Medicine News:Health News:Elderly immune system needs a boost 2Health News:As Teens Plug In, Parents Fret 2Health News:As Teens Plug In, Parents Fret 3Health News:Gross Germ-Spreading Behaviors Remain the Norm, Despite Flu Season Concerns 2Health News:Gross Germ-Spreading Behaviors Remain the Norm, Despite Flu Season Concerns 3Health News:Jackson & Coker Investigates the Impact of Social Media on Hospitals and Physicians 2Health News:Jackson & Coker Investigates the Impact of Social Media on Hospitals and Physicians 3Health News:Jackson & Coker Investigates the Impact of Social Media on Hospitals and Physicians 4Health News:Jackson & Coker Investigates the Impact of Social Media on Hospitals and Physicians 5Health News:Inoperable Colon Cancer Resolved After Four Months of New Treatment 2Health News:Inoperable Colon Cancer Resolved After Four Months of New Treatment 3
(Date:8/27/2014)... Aug. 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... of pharmaceutical development, clinical trial manufacturing, and advanced analytical ... that it will participate at the upcoming Rodman & ... be held in New York . ... on September 9, 2014 at the New York Palace ...
(Date:8/27/2014)... NORWALK, Conn. , Aug. 27, 2014  UBM ... , a leading online community for medical imaging professionals, ... Association for Medical Imaging Management,s 2014 Annual Meeting ... the conference coverage: , 11 Principles ... management can lead to greater profitability. , ...
(Date:8/27/2014)... DIEGO , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... and development of drugs targeting unmet needs in oncology, autoimmune ... Baird 2014 Health Care Conference to be held at The ... on September 3-4, 2014. Alan ... Company and its lead drug candidate, quizartinib, at 1:10 p.m. ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Ambit Announces Participation At Baird 2014 Health Care Conference 2
... Oramed Pharmaceuticals, Inc.,(OTCBB: ORMP.OB) ( http://www.oramed.com ), a ... to present at the 8th National Life,Science & Technology ... by Mr. Nadav Kidron, President and CEO of Oramed,on ... p.m. (local time),at the David Intercontinental Hotel in Tel-Aviv, ...
... Patients Demonstrated Improvement With Every-Four-Week Subcutaneous SIMPONI Despite ... , COPENHAGEN, June 9 A new analysis ... moderately to severely active rheumatoid arthritis (RA) who ... agents and received subcutaneous injections of SIMPONI(TM) (golimumab) ...
Cached Medicine Technology:Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009 2New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 2New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 3New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 4New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 5New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 6New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 7New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 8New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 9New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 10
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: